The Chronic Lymphocytic Leukemia Channel is supported with funding from AstraZeneca (Diamond), AbbVie (Platinum), BeOne Medicines (Silver) and Lilly (Silver).
The Lymphoma Channel is supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
iwCLL 2023 | The Lymphoma Coalition Global Patient survey: key gaps in health literacy
Lorna Warwick, BA, Lymphoma Coalition, Ontario, Canada, comments on the findings of the most recent Lymphoma Coalition Global Patient survey, with a focus on health literacy in patients with lymphomas and chronic lymphocytic leukemia (CLL). Although some medical terms used by healthcare teams are widely understood by patients, other key terms are not, emphasizing the need for verification of patient understanding so that they are able to fully participate in conversations about their care. This interview was recorded at the biennial International Workshop on Chronic Lymphocytic Leukemia (iwCLL) 2023 meeting, held in Boston, MA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
